Hepatitis delta virus infection in the Middle East
- PMID: 36205630
- DOI: 10.1111/liv.15450
Hepatitis delta virus infection in the Middle East
Comment in
-
Response to "Hepatitis delta virus infection in the Middle East".Liver Int. 2023 Jan;43(1):257. doi: 10.1111/liv.15451. Epub 2022 Oct 17. Liver Int. 2023. PMID: 36205593 No abstract available.
Comment on
-
Hepatitis delta virus infection prevalence, diagnosis and treatment in the Middle East: A scoping review.Liver Int. 2023 Aug;43 Suppl 1:116-123. doi: 10.1111/liv.15338. Epub 2022 Jun 29. Liver Int. 2023. PMID: 35689428
References
REFERENCES
-
- Lazarus JV, Al-Rifai A, Sanai FM, et al. Hepatitis delta virus infection prevalence, diagnosis and treatment in the Middle East: a scoping review. Liver Int. 2022. Published online June 11, 2022. doi: 10.1111/liv.15338
-
- Makhlouf NA, Morsy KH, Mahmoud AA. Hepatitis D virus infection among hepatitis B virus surface antigen positive individuals in upper Egypt: prevalence and clinical features. J Infect Public Health. 2019;12(3):350-356.
-
- Gomaa NI, Metwally LA, Nemr N, Younis S. Seroprevalence of HDV infection in HBsAg positive population in Ismailia. Egypt Egypt J Immunol. 2013;20(1):23-28.
-
- Fouad R, Abdo M, Eldeen HG, et al. Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D. J Med Virol. 2016;88(5):837-842.
-
- Elzefzafy W, Soliman R, Saleh L, et al. Seroprevalence and epidemiological characteristics of HDV infection among HBV patients in the Nile Delta. Egypt J Viral Hepat. 2022;29(1):87-90.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
